Quanta Pharma Aromasin is a pharmaceutical-grade exemestane preparation supplied as 50 tablets. Exemestane binds the aromatase enzyme permanently, which is why it produces less rebound than the reversible inhibitors. UK dispatch, tracked delivery.
Quanta Pharma Aromasin Specifications
Aromasin (Exemestane) 12.5mg by Quanta PharmaQuanta Pharma Aromasin Research Areas
- Little rebound: Permanent binding means the body must produce new enzyme, no sharp bounce on cessation
- Kinder to lipids: Reported as gentler on cholesterol than the reversible inhibitors, which matters on a long run
- Preferred into recovery: The forgiving option when transitioning off compounds
- Still an on-cycle tool: Controls oestrogen; it does not restart natural production
How Aromasin Works
Exemestane is a suicidal inhibitor: it binds the aromatase enzyme permanently rather than occupying it temporarily. That enzyme is finished, and the body has to synthesise new ones.
The practical consequence is a smoother exit than anastrozole or letrozole offer.
Exemestane vs Anastrozole
Anastrozole is the easier compound to titrate and the usual default. Exemestane wins where rebound or lipids are the concern, and going into a recovery phase.
Neither is PCT, see the SERM guides below.
Read Before You Buy
- Arimidex vs Aromasin vs Letrozole
- SERMs vs aromatase inhibitors, why an AI is not PCT
- Bloodwork: what to test
Why Choose Quanta Pharma Aromasin?
Pharmaceutical-grade tablets, consistent presentation and a traceable brand. Dispatched from the UK with tracked delivery.
⚠️ FOR LABORATORY RESEARCH USE ONLY
NOT FOR HUMAN OR VETERINARY DIAGNOSTIC OR THERAPEUTIC USE
Safety Classification:
For use by qualified research personnel only
Keep detailed records of usage and storage as per UK research regulations
Legal Notice: This product is exclusively intended for in vitro laboratory research conducted in controlled environments by trained professionals.
